Clinical Trial: The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder Cancer

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07873333) titled 'The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder Cancer' on Oct. 02.

Brief Summary: Bladder cancer is one of the most common malignancies worldwide and represents a major global health burden. According to the GLOBOCAN 2022 estimates, approximately 614,298 new cases and 220,596 deaths from bladder cancer were reported worldwide, making it the ninth most commonly diagnosed malignancy globally.

Non-muscle-invasive bladder cancer (NMIBC), comprising Ta, T1, and carcinoma in situ (CIS), accounts for approximately three-quarters of newly diagnosed bladder cancers. Although NMIBC is confined to the mucosa or submucosa, ...